IPXL Financial Facts

Selling, general and administrative: 48.31M
Patent litigation: 1.49M
See Full Income Statement

Other assets: 69.81M
Deferred income taxes, net: 133K
See Full Balance Sheet

Impax Laboratories Inc. (IPXL) Earnings

  |   Expand Research on IPXL
Next EPS Date 11/4/15 *Est. EPS Growth Rate -43.3% *Last Qtr.
Average EPS % Beat Rate -3.3% Revenue Growth Rate +13.9% *Last Qtr.
Average % Move 1-Wk after EPS -2.0% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/10/15 Q215 $0.34$0.35 -$0.01$214.2M$199.93M N/A Details
5/11/15 Q115 $0.09$0.18 -$0.09$143.1M$146M N/A Details
2/24/15 Q414 $0.16$0.12 +$0.04$131.2M$125.5M N/A Details
11/4/14 Q314 $0.33$0.31 +$0.02$158M$148.36M N/A Details
8/6/14 Q214 $0.60$0.36 +$0.24$188.1M$155.97M N/A Details
5/1/14 Q114 $0.24N/A N/A $106M$97.8M N/A Details
2/20/14 Q413 -$0.14$0.03 -$0.17$100.74M$119.01M N/A Details
11/4/13 Q313 $0.00-$0.07 +$0.07$132.6M$111.83M N/A Details